Methocarbamol and Evista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methocarbamol (methocarbamol) and Evista (raloxifene hydrochloride). Common drug interactions include arthralgia among females.

The phase IV clinical study analyzes what interactions people have when they take Methocarbamol and Evista. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Methocarbamol?

Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.



On Jul, 11, 2026

24 people who take Methocarbamol and Evista together, and have interactions are studied.

Methocarbamol and Evista drug interactions.

What are the common drug interactions of Methocarbamol and Evista, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Depression
  3. Constipation
  4. Diarrhoea
  5. Drug dependence
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dysuria (painful or difficult urination)
  8. Fat tissue increased
  9. Flat affect (absence of emotional response to a situation)
  10. Flatulence (flatus expelled through the anus)

male:

n/a

What are the common drug interactions of Methocarbamol and Evista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Headache (pain in head)
  3. Myalgia (muscle pain)
  4. Blood cholesterol increased
  5. Diabetes mellitus inadequate control
  6. Diabetic foot
  7. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  8. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Obesity (having too much body fat)

50-59:

  1. Dry mouth
  2. Eye pain
  3. Folliculitis (infection of hair root)
  4. Fracture
  5. Genital disorder female (diseases of female genital tract)
  6. Gingival bleeding (bleeding gums)
  7. Haematuria (presence of blood in urine)
  8. Hallucination (an experience involving the perception of something not present)
  9. Hallucinations, mixed (sensations that appear real but are created by your mind -mixed)
  10. Headache (pain in head)

60+:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Uterine polyp (a mass in the inner lining of the uterus)
  5. Abdominal discomfort
  6. Animal scratch
  7. Asthenia (weakness)
  8. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  9. Blister infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Blood calcium decreased

What are the existing conditions these people have? *

  1. Pain: 4 people, 16.67%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 16.67%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.50%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.50%
  5. Insomnia (sleeplessness): 2 people, 8.33%
  6. High Blood Pressure: 2 people, 8.33%
  7. High Blood Cholesterol: 2 people, 8.33%
  8. Gastritis (inflammation of stomach): 2 people, 8.33%
  9. Diabetes: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methocarbamol and Evista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methocarbamol and Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methocarbamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methocarbamol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol and raloxifene hydrochloride (the active ingredients of Methocarbamol and Evista, respectively), and Methocarbamol and Evista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: